| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $87.9B | $87.7B | $90.2B | $93.5B | $84.0B | $17.4B | $17.8B | $17.3B |
| Cost of Revenue | — | — | — | — | — | — | $16.7B | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $5.2B | $5.6B | $4.9B | $6.2B | $5.9B | $0.5B | $1.3B | $1.5B |
| Net Income | $4.1B | $4.3B | $4.0B | $3.8B | $5.2B | $-0.3B | $-2.0B | $1.1B |
| EPS (Basic) | $16.96 | $17.41 | $15.60 | $14.54 | $19.79 | $-1.28 | $-7.56 | $4.23 |
| EPS (Diluted) | $16.81 | $17.21 | $15.48 | $14.33 | $19.45 | $-1.28 | $-7.56 | $4.15 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $87.6B | $87.0B | $87.1B | $86.0B | $82.8B | $73.5B | $54.4B | $52.3B |
| Current Assets | $18.4B | $18.2B | $18.6B | $20.4B | $20.6B | $16.4B | $13.1B | $13.3B |
| Cash & Equivalents | $5.5B | $6.5B | $6.9B | $6.9B | $7.1B | $4.9B | $2.3B | $3.3B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $15.4B | $13.4B | $13.6B | $14.3B | $13.7B | $10.3B | $9.0B | $9.6B |
| Stockholders' Equity | $28.1B | $27.6B | $26.1B | $24.9B | $24.2B | $18.3B | $17.8B | $19.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $7.0B | $8.3B | $8.8B | $9.8B | $10.1B | $5.1B | $5.6B | $4.7B |
| Investing Cash Flow | $-4.1B | $-5.2B | $-6.2B | $-6.8B | $-6.0B | $-5.8B | $-5.5B | $-5.7B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-4.0B | $-3.4B | $-2.6B | $-3.0B | $-2.1B | $3.4B | $-1.0B | $0.2B |